抑制组蛋白甲基转移酶G9a激活自噬并在干眼病中提供保护
本研究探讨组蛋白甲基转移酶G9a在干眼病中的表达动态与功能作用,采用高渗培养基(90 mM NaCl)培养的人角膜上皮细胞体外模型及0.075%苯扎氯铵滴眼液每日两次持续14天的小鼠体内模型。结果显示G9a表达在体外干眼模型中显著下调且由mTOR信号介导,药物抑制G9a通过减少炎症、凋亡和氧化应激并增强自噬流减轻损伤,机制为降低ATG7启动子H3K9me2占据、解除转录沉默;体内抑制G9a改善眼表完整性、增加泪液分泌、恢复杯状细胞密度并减少角膜炎症标志物表达。
要点
- 体外干眼模型中G9a表达显著下调,该下调由mTOR信号介导。
- 药物抑制G9a通过减少炎症、凋亡和氧化应激并增强自噬流减轻角膜上皮细胞损伤。
- G9a抑制通过降低ATG7启动子H3K9me2占据、解除转录沉默来增强自噬。
核心结论
- G9a下调通过促进自噬在干眼病中发挥保护作用,机制为G9a抑制减少H3K9me2介导的ATG7转录沉默。
- G9a-自噬轴在体外和体内模型中均对干眼病提供显著保护。
研究设计与样本
- 体外模型:人角膜上皮细胞(HCEC)在高渗培养基(90 mM NaCl)中培养建立干眼模型。
- 体内模型:小鼠接受0.075%苯扎氯铵滴眼液每日两次、持续14天处理。
- 采用实时定量PCR、蛋白质印迹、免疫荧光染色、流式细胞术和染色质免疫沉淀进行表型与机制分析。
- 疾病严重度采用荧光素钠染色和酚红棉线试验评估,组织病理学分析包括过碘酸-雪夫染色、苏木精-伊红染色和免疫组化。
主要发现
- G9a表达在体外干眼模型中显著下调,该下调由mTOR信号介导。
- 药物抑制G9a通过减少炎症、凋亡和氧化应激并增强自噬流减轻HCEC中干眼诱导的损伤。
- G9a抑制减轻ATG7启动子处的转录抑制,降低H3K9me2占据并促进自噬。
- 体内G9a抑制改善疾病结局:增强眼表完整性并增加泪液分泌、恢复杯状细胞密度、减少角膜炎症标志物表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to investigate the expression dynamics and functional role of the histone methyltransferase G9a in dry eye disease (DED). METHODS: An in vitro DED model was established using human corneal epithelial cells (HCECs) cultured in hyperosmotic medium (90-mM NaCl). For the in vivo model, mice were treated with 0.075% benzalkonium chloride eye drops twice daily for 14 days. Phenotypic and mechanistic analyses were conducted using quantitative real-time PCR, western blotting, immunofluorescence staining, flow cytometry, and chromatin immunoprecipitation assays. Disease severity was assessed by fluorescein sodium staining and the phenol red thread test. Histopathological analysis included periodic acid-Schiff staining, hematoxylin and eosin staining, and immunohistochemistry. RESULTS: G9a expression was significantly downregulated in the in vitro DED model, which was mediated by mammalian target of rapamycin (mTOR) signaling. Pharmacological inhibition of G9a mitigated DED-induced damage in HCECs by reducing inflammation, apoptosis, and oxidative stress while enhancing autophagic flux. Mechanistically, G9a inhibition alleviated transcriptional repression at the autophagy-related 7 (ATG7) promoter, decreasing H3K9me2 occupancy and promoting autophagy. In vivo, G9a inhibition improved disease outcomes, including (1) enhanced ocular surface integrity and increased tear production, (2) restoration of goblet cell density, and (3) reduced expression of corneal inflammatory markers. CONCLUSIONS: G9a downregulation confers protective effects in DED by promoting autophagy. Mechanistically, G9a inhibition enhances autophagy through the reduction of H3K9me2-mediated transcriptional silencing of ATG7. This G9a-autophagy axis offers significant protection against DED in both in vitro and in vivo models.
引用
- Chen Z, Tang Y, Jiang J, et al. Inhibition of Histone Methyltransferase G9a Activates Autophagy and Provides Protection in Dry Eye Disease. Invest Ophthalmol Vis Sci. 2025. PMID: 41263610. doi:10.1167/iovs.66.14.52
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。